知镜 Cognispect · 医学文献与研究工作台

Depression and anxiety diagnosis and treatment rates among subgroups of people with epilepsy.

Conner K, Paukner L, Rigdon J, Gillette C.
Epilepsy & behavior : E&B · 2026-09-27 · PMID 42801847

文献摘要

Background People with epilepsy (PWE) experience higher rates of depression and anxiety than the general population, but racial and ethnic differences in mental health diagnoses and treatment within PWE are not well characterized. Objective To evaluate racial and ethnic disparities in depression and anxiety diagnoses, antidepressant use, and drug-resistant epilepsy (DRE) designation among adults with epilepsy compared to White, non-Hispanic PWE. Methods This retrospective cohort study from the All of Us database included 6,337 PWE. Multivariate logistic regression estimated adjusted odds ratios (aORs) with 95% confidence intervals (CIs), using White, non-Hispanic PWE as the reference group. Chi-square tests were used for unadjusted comparisons among participants with DRE. Results Compared to White, non-Hispanic PWE, Black, non-Hispanic PWE were less likely to be diagnosed with depression (lifetime: aOR 0.84 [95% CI, 0.71-0.99]; within one year: aOR 0.77 [0.61-0.96]) or anxiety (lifetime: aOR 0.61 [0.51-0.74]; within one year: aOR 0.64 [0.54-0.75]). Hispanic PWE were less likely to be diagnosed with anxiety within one year of epilepsy diagnosis (aOR 0.82 [0.68-0.99]) and to receive antidepressant therapy (aOR 0.71 [0.56-0.89]). DRE was defined as more than two antiseizure medications prescribed each for at least six months after initial epilepsy diagnosis. Black, non-Hispanic (χ 2 = 6.45; p = 0.011) and Hispanic PWE (χ 2 = 17.4; p Conclusions Racial and ethnic disparities exist in mental health diagnoses, treatment, and DRE designation among PWE, highlighting the need for more equitable screening and care.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。